Vincent P Mihalik Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Vincent P Mihalik.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Vincent P Mihalik. Vincent P Mihalik is SVP Chief Commercial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP Sales and Marketing, CCO in AMYLIN PHARMACEUTICALS INC ($AMLN) and SVP, Chief Commercial Officer in AMYLIN PHARMACEUTICALS INC ($AMLN).
Latest Insider Trading Transactions of Vincent P Mihalik
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 0.00 | 85,000 | 0 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 18.01 | 48,968 | 881,914 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 16.02 | 42,979 | 688,524 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 15.03 | 33,593 | 504,903 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 13.05 | 34,514 | 450,408 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 18.01 | 6,032 | 108,636 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 16.02 | 7,021 | 112,476 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 15.03 | 6,407 | 96,297 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | J | 13.05 | 25,486 | 332,592 | 0 | |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 1,360 | 42,160 | 0 | 1.4 K to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 1,360 | 42,160 | 1,360 | 2.7 K to 1.4 K (-50.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 1,799 | 55,769 | 2,720 | 4.5 K to 2.7 K (-39.81 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 453 | 14,043 | 0 | 453 to 0 (-100.00 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 885 | 27,435 | 453 | 1.3 K to 453 (-66.14 %) |
| Aug 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | J | 31.00 | 39,917 | 1,237,427 | 0 | 39.9 K to 0 (-100.00 %) |
| Jul 26 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Grant | A | 14.62 | 890 | 13,012 | 39,917 | 39 K to 39.9 K (+2.28 %) |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | A | 16.02 | 42,979 | 688,524 | 42,979 | |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | A | 16.02 | 7,021 | 112,476 | 7,021 | |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Grant | A | 0.00 | 1,529 | 0 | 4,519 | 3 K to 4.5 K (+51.14 %) |
| Mar 07 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Grant | A | 0.00 | 10,000 | 0 | 39,027 | 29 K to 39 K (+34.45 %) |
| Mar 02 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | S | 17.11 | 1,231 | 21,062 | 29,027 | 30.3 K to 29 K (-4.07 %) |
| Feb 24 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | S | 17.03 | 7,518 | 128,033 | 29,657 | 37.2 K to 29.7 K (-20.22 %) |
| Feb 24 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Grant | A | 0.00 | 20,000 | 0 | 37,175 | 17.2 K to 37.2 K (+116.45 %) |
| Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Sell | S | 16.62 | 3,842 | 63,838 | 17,175 | 21 K to 17.2 K (-18.28 %) |
| Feb 10 2012 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Grant | A | 0.00 | 10,000 | 0 | 21,017 | 11 K to 21 K (+90.77 %) |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | A | 15.03 | 33,593 | 504,903 | 33,593 | |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Option Exercise | A | 15.03 | 6,407 | 96,297 | 6,407 | |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Grant | A | 0.00 | 1,630 | 0 | 2,990 | 1.4 K to 3 K (+119.85 %) |
| Mar 03 2011 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP, Chief Commerci ... | Grant | A | 0.00 | 10,000 | 0 | 10,432 | 432 to 10.4 K (+2,314.81 %) |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Chief Commerci ... | Option Exercise | A | 18.01 | 48,968 | 881,914 | 48,968 | |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Chief Commerci ... | Option Exercise | A | 18.01 | 6,032 | 108,636 | 6,032 | |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Chief Commerci ... | Grant | A | 0.00 | 1,360 | 0 | 1,360 | 0 to 1.4 K |
| Feb 04 2010 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Chief Commerci ... | Grant | A | 17.83 | 412 | 7,346 | 412 | 0 to 412 |
| Mar 06 2009 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Sales and Marke ... | Option Exercise | A | 9.02 | 30,000 | 270,600 | 30,000 | |
| Feb 11 2009 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Sales and Marke ... | Option Exercise | A | 13.05 | 34,514 | 450,408 | 34,514 | |
| Feb 11 2009 | AMLN | AMYLIN PHARMACEUTI ... | Mihalik Vincent P | SVP Sales and Marke ... | Option Exercise | A | 13.05 | 25,486 | 332,592 | 25,486 |
Page: 1